REGISTER HERE Webinar overview State cannabis markets are in a period of rapid transition, due to: 1) federal marijuana rescheduling developments, 2) the coming federal prohibition on intoxicating hemp products and high THC seeds, and 3) the 2026 midterm election results. This webinar will feature Harris Sliwoski attorneys Jason Adelstone (CO, NM, AZ), Jared Schwass
On Friday, October 30, the Justice Department announced the issuance of federal registrations for medical marijuana dispensaries. Simultaneously, DEA released its Timely Applicant information, outlining operational requirements for applicants that sought registration during the expedited application window between April 28 and June 26, 2026. The Timely Applicant information defines a “Timely Applicant” as a state
With the 2026 midterm elections approaching, cannabis reform is once again part of the political conversation. From state-level legalization efforts to the future of federal cannabis policy, the elections could have important implications for the industry. Harris Sliwoski Managing Partner Vince Sliwoski joined NBC News NOW on October 27 to discuss cannabis reform in the
Recently on the podcast High Spirits: The Cannabis Business Podcast, I discussed how cannabis legalization can occur through executive action, not just congressional action. This post will expand on what we discussed on the podcast. My co-founder, Amna Shamim, and I started Project Four 2029 to engage with presidential and congressional candidates ahead of the
Colorado regulates marijuana businesses through the state Marijuana Enforcement Division (MED), while local jurisdictions retain separate licensing and regulatory authority over marijuana businesses within their boundaries. The current Colorado Marijuana Rules are codified at 1 CCR 212-3 (version effective January 5, 2026). Because state rules, forms, fee schedules, and local ordinances can change, applicants should
With so much of my attention focused on U.S. rescheduling lately, I wanted to take advantage of the D.C. Circuit’s delay and the DEA ALJ’s delayed timeline. This gives me an opportunity to get back into some considerations on international cannabis reform. Who controls government is one of the most important factors when discussing cannabis
Cannabis law has never been more contradictory. In the U.S., federal and state governments often regulate identical products under completely different legal frameworks. Hemp and marijuana can produce the same intoxicating effects, yet lawmakers treat them as fundamentally different. Medical marijuana now occupies a unique place under federal law while adult use marijuana remains prohibited.
The hearing on the Notice of Proposed Rulemaking for the rescheduling of “marijuana” commenced on June 29, 2026 and will end tomorrow, July 15th. The Government brought two witnesses to the stand on the first day, and then seven prohibitionist organizations had the floor for the remaining seven days of the hearing. As I discussed
On April 28, 2026, Acting Attorney General Blanche (“AG”) issued a notice of hearing concerning the proposed rule to move marijuana from Schedule I to Schedule III of the Controlled Substances Act (“CSA”). The notice replaced the hearing that began in December 2024 (“2024 Hearing”), which the AG terminated upon issuing the new notice. The
Sine die came for Oregon’s 2026 legislative session last Friday, March 6th. I previewed the roster of cannabis bills in play back on February 12th. Two of them passed; two of them failed. Below is a recap of the action, with links to each bill in the headers. HB 4139 (FAILED) This was the session’s
